IDEXX LABORATORIES INC /DE Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2013-01-31)
IDEXX LABORATORIES INC /DE (IDXX) reported Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2013-01-31) of -$641.00 thousand for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-07-23.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax · last filed 2013-07-23
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2013-01-31) for the quarter ending 2013-06-30 was -$641.00K.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2013-01-31) for the quarter ending 2013-03-31 was -$10.00K.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2013-01-31) for the quarter ending 2012-12-31 was -$431.00K, a 181.78% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2013-01-31) for the quarter ending 2012-09-30 was -$872.00K, a 173.15% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2013-01-31) for fiscal 2012 was -$3.63M, a 178.29% decline from fiscal 2011.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2013-01-31) for fiscal 2011 was $4.63M, a 297.42% increase from fiscal 2010.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2013-01-31) for fiscal 2010 was $1.17M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2013-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2013-01-31) 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2013-01-31) 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$641.00K 10-Q · filed 2013-07-23 | -$651.00K 10-Q · filed 2013-07-23 | -$1.08M derived: sum of 3 quarters · filed 2013-07-23 | -$1.95M derived: sum of 4 quarters · filed 2013-07-23 |
| 2013-03-31 | -$10.00K 10-Q · filed 2013-04-23 | -$441.00K derived: sum of 2 quarters · filed 2013-04-23 | -$1.31M derived: sum of 3 quarters · filed 2013-04-23 | -$2.84M derived: sum of 4 quarters · filed 2013-07-23 |
| 2012-12-31 | -$431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | -$1.30M derived: sum of 2 quarters · filed 2013-02-19 | -$2.83M derived: sum of 3 quarters · filed 2013-07-23 | -$3.63M 10-K · filed 2013-02-19 |
| 2012-09-30 | -$872.00K 10-Q · filed 2012-10-19 | -$2.40M derived: sum of 2 quarters · filed 2013-07-23 | -$3.19M 10-Q · filed 2012-10-19 | -$2.67M derived: sum of 4 quarters · filed 2013-07-23 |
| 2012-06-30 | -$1.53M 10-Q · filed 2013-07-23 | -$2.32M 10-Q · filed 2013-07-23 | -$1.79M derived: sum of 3 quarters · filed 2013-07-23 | -$603.00K derived: sum of 4 quarters · filed 2013-07-23 |
| 2012-03-31 | -$795.00K 10-Q · filed 2013-04-23 | -$268.00K derived: sum of 2 quarters · filed 2013-04-23 | $924.00K derived: sum of 3 quarters · filed 2013-04-23 | $2.73M derived: sum of 4 quarters · filed 2013-04-23 |
| 2011-12-31 | $527.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $1.72M derived: sum of 2 quarters · filed 2013-02-19 | $3.52M derived: sum of 3 quarters · filed 2013-02-19 | $4.63M 10-K · filed 2013-02-19 |
| 2011-09-30 | $1.19M 10-Q · filed 2012-10-19 | $3.00M derived: sum of 2 quarters · filed 2012-10-19 | $4.10M 10-Q · filed 2012-10-19 | |
| 2011-06-30 | $1.80M 10-Q · filed 2012-07-20 | $2.91M 10-Q · filed 2012-07-20 | ||
| 2010-12-31 | $1.17M 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |